Pilot Study of Stereotactic Ablation for Oligometastatic Breast Neoplasia in Combination With the Anti-PD-1 Antibody MK-3475 (BOSTON II)

Clinical Trial ID NCT02303366

PubWeight™ 5.28^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02303366

Top papers